Animal study finds ketogenic diet increases small intestinal tumor development in predisposed mice — Evidence Review
Published in Nature, by researchers from Massachusetts Institute of Technology
Researched by
— the AI search engine for science
Table of Contents
A new study from MIT finds that a ketogenic diet increases small intestine tumor risk in genetically predisposed mice, contrasting with prior research suggesting anti-tumor effects, especially in the colon. Most related studies report protective or neutral effects of ketogenic diets on cancer, so these new results highlight important tissue-specific risks not previously recognized.
- While prior animal studies generally observed anti-tumor effects of ketogenic diets, particularly in colon cancer models, none reported increased tumor risk in the small intestine, making this finding novel and significant 1 3 6 7 8.
- Some recent research raises concerns about potential pro-tumor or metastasis-promoting effects of ketogenic diets in specific circumstances, indicating that their impact may depend on tumor type, location, and underlying genetics 4.
- Clinical studies in humans remain inconclusive, with generally weak evidence for either strong anti-tumor or pro-tumor effects, and highlight the need for cautious interpretation and further research 1 2.
Study Overview and Key Findings
This study addresses a timely question, given the popularity of ketogenic diets for weight loss and health. While previous research suggested that these diets might protect against certain cancers, particularly colon cancer, the new findings reveal a potential risk of increased tumor development in the small intestine. The study is notable for investigating tissue-specific effects within the gastrointestinal tract, showing that dietary interventions can have differing impacts on closely related organs.
| Property | Value |
|---|---|
| Organization | Massachusetts Institute of Technology |
| Journal Name | Nature |
| Authors | Omer Yilmaz, Jessica Shay, Fangtao Chi, Alex K. Shalek, Matthew Vander Heiden |
| Population | Mice genetically predisposed to developing intestinal cancer |
| Methods | Animal Study |
| Outcome | Tumor development in small intestine and colon |
| Results | Ketogenic diet increased small intestinal tumors in mice |
Literature Review: Related Studies
We searched the Consensus paper database, which includes over 200 million research papers, to identify studies relevant to the relationship between ketogenic diets, fat intake, and cancer risk. The following search queries were used:
| Topic | Key Findings |
|---|---|
| Do ketogenic diets have anti-tumor effects in animal and human cancer models? | - Animal studies show overall anti-tumor effects of ketogenic diets, especially in colon cancer models, with delayed tumor growth and reduced tumor weight/volume 1 3 6 7 8. - Human evidence for anti-tumor effects of ketogenic diets is weak, inconclusive, and limited to individual cases 1 2. |
| Can ketogenic or high-fat diets also promote tumor growth or metastasis? | - Some studies find that high-fat diets may increase tumor risk in specific tissues (e.g., pancreas, liver, small intestine) or promote metastasis under certain genetic or molecular conditions 4 10 11 12 13 14. - The new MIT study is the first to report increased small intestinal tumor risk with a ketogenic diet, highlighting a tissue-specific pro-tumor effect 4. |
| What mechanisms underlie the effects of ketogenic and high-fat diets on cancer? | - Anti-tumor effects have been linked to ketone bodies (e.g., BHB) suppressing proliferation, immune modulation, and metabolic changes 6 9. - Pro-tumor effects are associated with increased fatty acid oxidation, stem cell proliferation, inflammation, and oncogene activation, rather than ketone bodies per se 4 10 11 12. |
| How does cancer type, genetic background, and tissue location affect dietary impacts? | - The response to ketogenic and high-fat diets varies by cancer type, genetic predisposition, and tissue; colon tumors often decrease, while pancreatic, liver, or small intestinal tumors may increase 3 4 6 7 10 11 13 14. - Animal models with specific oncogenic mutations show differential responses to diet, underscoring the complexity of cancer-diet interactions 10 11 12 13 14. |
Do ketogenic diets have anti-tumor effects in animal and human cancer models?
Most animal studies, particularly in colon cancer models, report that ketogenic diets slow tumor growth, reduce tumor size, or prolong survival, likely due to metabolic changes that disadvantage cancer cells. However, the evidence in humans is much weaker, with no conclusive demonstration of broad anti-tumor or survival benefits in clinical trials. The new MIT study contrasts with this trend by identifying a tissue-specific pro-tumor effect in the small intestine.
- Pre-clinical animal studies show delayed tumor growth and reduced tumor weight with ketogenic diets, especially in colorectal cancer models 1 3 6 7 8.
- Human trials are inconclusive, with low adherence and heterogeneity limiting confidence in results; anti-tumor effects remain unproven in clinical settings 1 2.
- Prior studies did not report increased tumor risk with ketogenic diets in animal models, making the MIT findings notable 1 3.
- The potential benefits in colon cancer may not generalize to other gastrointestinal tissues 6 7 8.
Can ketogenic or high-fat diets also promote tumor growth or metastasis?
Emerging research suggests that under certain circumstances, high-fat or ketogenic diets can promote tumor growth or metastasis, particularly in tissues other than the colon or in genetically susceptible animals. The new MIT study is the first to show increased small intestine tumor risk with a ketogenic diet, and other studies point to increased risk of pancreatic and liver cancer or metastasis with high-fat diets.
- High-fat diets increase pancreatic and liver cancer risk in genetically predisposed mice, likely via inflammation and oncogene activation 10 11 12 13 14.
- A recent study found that the ketogenic diet can promote tumor metastasis by modulating BACH1-mediated transcription, though this effect may depend on specific molecular pathways 4.
- The MIT study suggests that increased fatty acid oxidation, not ketone bodies, drives small intestinal tumorigenesis 4.
- No previous research reported pro-tumor effects of ketogenic diets in the small intestine 1 3.
What mechanisms underlie the effects of ketogenic and high-fat diets on cancer?
Beneficial anti-tumor effects have been attributed to ketone bodies (such as β-hydroxybutyrate) inhibiting cell proliferation and modulating immune responses. In contrast, the pro-tumor effects observed in some studies are linked to increased fatty acid oxidation, stem cell proliferation, inflammation, and the activation of oncogenic pathways. The MIT study provides direct evidence that fatty acid metabolism, rather than ketone bodies, underlies increased small intestinal tumor risk.
- β-hydroxybutyrate was previously thought to suppress colorectal cancer, but the MIT study found it was not responsible for increased small intestine tumors 6.
- Immune modulation (e.g., increased T cell surveillance) is another mechanism by which ketogenic diets can affect tumor growth 9.
- Inflammation and activation of specific oncogenes (e.g., KRAS, COX2) are implicated in diet-induced pancreatic and liver cancers 10 11 12 13 14.
- Tissue-specific metabolic pathways determine whether a high-fat or ketogenic diet has a protective or harmful effect 4 6.
How does cancer type, genetic background, and tissue location affect dietary impacts?
The effect of ketogenic and high-fat diets is highly context-dependent. Colon tumors tend to decrease with ketogenic diets, while pancreatic, liver, and now small intestinal tumors may increase in genetically susceptible models. Different tissues respond differently to dietary fats and ketone bodies, and genetic mutations (e.g., in KRAS) can modulate these effects.
- Colon cancer models consistently show anti-tumor effects of ketogenic diets, while other GI tract tissues do not necessarily share this response 3 6 7 8.
- Pancreatic and liver tumor models, especially with oncogenic mutations, show increased risk with high-fat diets 10 11 12 13 14.
- The MIT study demonstrates that even within the intestine, adjacent tissues (small intestine vs. colon) can have opposing responses to the same diet 4.
- Genetic predisposition (e.g., familial cancer syndromes) may amplify tissue-specific risks 4 10 11 13.
Future Research Questions
The divergent findings between different tissues and models highlight the need for further investigation into how ketogenic and high-fat diets interact with cancer risk. Future research should clarify the mechanisms underlying these tissue-specific effects, determine their relevance to humans, and identify which populations may be at increased risk or benefit from these dietary patterns.
| Research Question | Relevance |
|---|---|
| Why does a ketogenic diet increase small intestinal but not colon tumor risk? | Understanding the tissue-specific mechanisms will help clarify the risks and benefits of ketogenic diets and guide safe dietary recommendations 4 6. |
| Are the pro-tumor effects of high-fat diets in mice relevant to human cancer risk? | Translational studies are needed to determine if findings from rodent models apply to human populations, particularly for cancers beyond the colon 1 2 4 10 11. |
| Can modifying fatty acid metabolism reduce tumor risk in patients on ketogenic diets? | Since fatty acid oxidation (not ketone bodies) was linked to tumor formation, interventions targeting this pathway may mitigate risk 4 10 12. |
| Which genetic or molecular markers predict cancer risk from high-fat or ketogenic diets? | Identifying susceptible individuals could allow for personalized dietary recommendations and risk stratification 10 11 13. |
| What are the long-term effects of ketogenic diets on cancer incidence and survival in humans? | Long-term, well-controlled human studies are needed to assess the safety and efficacy of ketogenic diets for cancer prevention or therapy 1 2. |